The company refused the FDA’s request and will continue shipping its therapy, Elevidys, to Duchenne patients who can still ...

By Zachary Stieber Contributing Writer Sarepta Therapeutics will not agree to a regulatory request to pause shipments of a ...

Sarepta Therapeutics (SRPT) stock is in focus after the US Food and Drug Administration (FDA) asked the company to halt ...

Stocks were rising Monday as Wall Street monitored the latest trade developments, digested a number of earnings reports, and ...